CHU Nantes

Nantes 2 trials 1 recruiting

2 Registered trials

1 Currently recruiting

Organisation

CHU Nantes

Location

Nantes, France

Identifier

ORL-000010007

Address

1 Place Alexis Ricordeau, 44093, France

Departments

Hematology
Service d'Hématologie

Clinical trials at this site (2)

Search interface

A Phase 3 Study of a GPRC5D-directed CAR T Cell Therapy in Participants with Relapsed or Refractory Multiple Myeloma and Exposed to Lenalido… Recruiting

2024-515279-37-00 Relapsed or Refractory and Lenalidomide exposed Multipl 5 2025-04-17
A Phase 1 Open-label, Multicenter, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of HPN217 in Patients with Relaps… Ended

2024-515582-33-00 Relapsed/Refractory Multiple Myeloma (RRMM) 1 2020-10-26